
### [MONDO:0000009](http://purl.obolibrary.org/obo/MONDO_0000009)
**Label:** bleeding disorder, platelet-type

**Subclasses:** [MONDO:0012031](http://purl.obolibrary.org/obo/MONDO_0012031) (platelet-type bleeding disorder 10), [MONDO:0013597](http://purl.obolibrary.org/obo/MONDO_0013597) (platelet-type bleeding disorder 14), [MONDO:0014830](http://purl.obolibrary.org/obo/MONDO_0014830) (platelet-type bleeding disorder 20), [MONDO:0009276](http://purl.obolibrary.org/obo/MONDO_0009276) (Bernard-Soulier syndrome), [MONDO:0012354](http://purl.obolibrary.org/obo/MONDO_0012354) (platelet-type bleeding disorder 8), [MONDO:0013141](http://purl.obolibrary.org/obo/MONDO_0013141) (autosomal dominant macrothrombocytopenia TUBB1-related), [MONDO:0014078](http://purl.obolibrary.org/obo/MONDO_0014078) (platelet-type bleeding disorder 15), [MONDO:0008552](http://purl.obolibrary.org/obo/MONDO_0008552) (platelet-type bleeding disorder 16), [MONDO:0008332](http://purl.obolibrary.org/obo/MONDO_0008332) (platelet-type bleeding disorder 3), [MONDO:0014386](http://purl.obolibrary.org/obo/MONDO_0014386) (platelet-type bleeding disorder 18), [MONDO:0008553](http://purl.obolibrary.org/obo/MONDO_0008553) (platelet-type bleeding disorder 17), [MONDO:0009885](http://purl.obolibrary.org/obo/MONDO_0009885) (Scott syndrome), [MONDO:0015372](http://purl.obolibrary.org/obo/MONDO_0015372) (autosomal dominant macrothrombocytopenia), [MONDO:0007954](http://purl.obolibrary.org/obo/MONDO_0007954) (May-Hegglin anomaly), [MONDO:0007930](http://purl.obolibrary.org/obo/MONDO_0007930) (Bernard-Soulier syndrome, type A2, autosomal dominant), [MONDO:0007686](http://purl.obolibrary.org/obo/MONDO_0007686) (gray platelet syndrome), [MONDO:0011588](http://purl.obolibrary.org/obo/MONDO_0011588) (platelet-type bleeding disorder 12), [MONDO:0011136](http://purl.obolibrary.org/obo/MONDO_0011136) (Quebec platelet disorder), [MONDO:0014518](http://purl.obolibrary.org/obo/MONDO_0014518) (platelet-type bleeding disorder 19), [MONDO:0010119](http://purl.obolibrary.org/obo/MONDO_0010119) (Glanzmann's thrombasthenia), [MONDO:0013622](http://purl.obolibrary.org/obo/MONDO_0013622) (platelet-type bleeding disorder 9), [MONDO:0013524](http://purl.obolibrary.org/obo/MONDO_0013524) (bleeding diathesis due to thromboxane synthesis deficiency), [MONDO:0013623](http://purl.obolibrary.org/obo/MONDO_0013623) (platelet-type bleeding disorder 11), 

**Corr. equiv. classes:** [OMIM:605735](http://purl.obolibrary.org/obo/OMIM_605735), [OMIM:608404](http://purl.obolibrary.org/obo/OMIM_608404), [OMIM:155100](http://purl.obolibrary.org/obo/OMIM_155100), [OMIM:616176](http://purl.obolibrary.org/obo/OMIM_616176), [OMIM:139090](http://purl.obolibrary.org/obo/OMIM_139090), [OMIM:614158](http://purl.obolibrary.org/obo/OMIM_614158), [OMIM:601709](http://purl.obolibrary.org/obo/OMIM_601709), [OMIM:231200](http://purl.obolibrary.org/obo/OMIM_231200), [Orphanet:466806](http://www.orpha.net/ORDO/Orphanet_466806), [OMIM:615888](http://purl.obolibrary.org/obo/OMIM_615888), [Orphanet:420566](http://www.orpha.net/ORDO/Orphanet_420566), [OMIM:616913](http://purl.obolibrary.org/obo/OMIM_616913), [Orphanet:220436](http://www.orpha.net/ORDO/Orphanet_220436), [OMIM:187800](http://purl.obolibrary.org/obo/OMIM_187800), [OMIM:187900](http://purl.obolibrary.org/obo/OMIM_187900), [Orphanet:52530](http://www.orpha.net/ORDO/Orphanet_52530), [OMIM:273800](http://purl.obolibrary.org/obo/OMIM_273800), [Orphanet:274](http://www.orpha.net/ORDO/Orphanet_274), [OMIM:609821](http://purl.obolibrary.org/obo/OMIM_609821), [OMIM:153670](http://purl.obolibrary.org/obo/OMIM_153670), [OMIM:615193](http://purl.obolibrary.org/obo/OMIM_615193), [OMIM:262890](http://purl.obolibrary.org/obo/OMIM_262890), [OMIM:177820](http://purl.obolibrary.org/obo/OMIM_177820), [Orphanet:140957](http://www.orpha.net/ORDO/Orphanet_140957), [OMIM:614201](http://purl.obolibrary.org/obo/OMIM_614201), [Orphanet:220443](http://www.orpha.net/ORDO/Orphanet_220443), [OMIM:613112](http://purl.obolibrary.org/obo/OMIM_613112), [OMIM:614200](http://purl.obolibrary.org/obo/OMIM_614200), [Orphanet:849](http://www.orpha.net/ORDO/Orphanet_849), [Orphanet:438207](http://www.orpha.net/ORDO/Orphanet_438207), [Orphanet:806](http://www.orpha.net/ORDO/Orphanet_806), [OMIM:614009](http://purl.obolibrary.org/obo/OMIM_614009), [Orphanet:36355](http://www.orpha.net/ORDO/Orphanet_36355), [Orphanet:98885](http://www.orpha.net/ORDO/Orphanet_98885), [Orphanet:721](http://www.orpha.net/ORDO/Orphanet_721), [Orphanet:98886](http://www.orpha.net/ORDO/Orphanet_98886), 

**Class expressions from DL-Learner:**

- [HP:0000132](http://purl.obolibrary.org/obo/HP_0000132) (Menorrhagia) and [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) 57.73%
- [HP:0000132](http://purl.obolibrary.org/obo/HP_0000132) (Menorrhagia) and [HP:0000366](http://purl.obolibrary.org/obo/HP_0000366) (Abnormality of the nose) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) 57.73%
- [HP:0000132](http://purl.obolibrary.org/obo/HP_0000132) (Menorrhagia) and [HP:0000271](http://purl.obolibrary.org/obo/HP_0000271) (Abnormality of the face) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) 57.73%
- [HP:0000132](http://purl.obolibrary.org/obo/HP_0000132) (Menorrhagia) and [HP:0000234](http://purl.obolibrary.org/obo/HP_0000234) (Abnormality of the head) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) 57.73%
- [HP:0000132](http://purl.obolibrary.org/obo/HP_0000132) (Menorrhagia) and [HP:0000152](http://purl.obolibrary.org/obo/HP_0000152) (Abnormality of head or neck) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) 57.73%
- [HP:0000132](http://purl.obolibrary.org/obo/HP_0000132) (Menorrhagia) and [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) 57.73%
- [HP:0000132](http://purl.obolibrary.org/obo/HP_0000132) (Menorrhagia) and [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) and [HP:0011276](http://purl.obolibrary.org/obo/HP_0011276) (Vascular skin abnormality) 57.73%
- [HP:0000132](http://purl.obolibrary.org/obo/HP_0000132) (Menorrhagia) and [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 57.73%
- [HP:0000132](http://purl.obolibrary.org/obo/HP_0000132) (Menorrhagia) and [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) and [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) 57.73%
- [HP:0000132](http://purl.obolibrary.org/obo/HP_0000132) (Menorrhagia) and [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) and [HP:0001933](http://purl.obolibrary.org/obo/HP_0001933) (Subcutaneous hemorrhage) 57.73%
- [HP:0000132](http://purl.obolibrary.org/obo/HP_0000132) (Menorrhagia) and [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) 57.73%
- [HP:0000132](http://purl.obolibrary.org/obo/HP_0000132) (Menorrhagia) and [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) 57.73%
- [HP:0000132](http://purl.obolibrary.org/obo/HP_0000132) (Menorrhagia) and [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0000951](http://purl.obolibrary.org/obo/HP_0000951) (Abnormality of the skin) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) 57.73%
- [HP:0000132](http://purl.obolibrary.org/obo/HP_0000132) (Menorrhagia) and [HP:0000366](http://purl.obolibrary.org/obo/HP_0000366) (Abnormality of the nose) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) 57.73%
- [HP:0000132](http://purl.obolibrary.org/obo/HP_0000132) (Menorrhagia) and [HP:0000366](http://purl.obolibrary.org/obo/HP_0000366) (Abnormality of the nose) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) and [HP:0011276](http://purl.obolibrary.org/obo/HP_0011276) (Vascular skin abnormality) 57.73%


